Eliglustat prevents acute kidney injury caused by Shiga toxin 2 in lethal and sublethal rat models of hemolytic uremic syndrome. [PDF]
Sánchez DS +3 more
europepmc +1 more source
Lysophosphatidylcholine as a Novel Diagnostic Biomarker in Kawasaki Disease: Based on Immunometabolism-Related Signature. [PDF]
Ma X +5 more
europepmc +1 more source
In Vitro Investigation of Glucosylceramide-Mediated Brain-Targeting in Water-in-Oil-in-Water Nanoemulsions Containing Astaxanthin, Curcumin, and Sesame Oil. [PDF]
Poyenyate K, Yata T, Angkanaporn K.
europepmc +1 more source
Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson's disease brain. [PDF]
Hällqvist J +14 more
europepmc +1 more source
The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. [PDF]
Jennemann R, Sandhoff R.
europepmc +1 more source
RNA-based therapeutic interventions for the management of Anderson-Fabry disease. [PDF]
Cagnin S.
europepmc +1 more source
Two lysosomal genes ATP13A2 and GBA1 interact to drive neurodegeneration. [PDF]
Gu M +17 more
europepmc +1 more source
Glucosylceramide regulates depression through activating peroxisome proliferator-activated receptor gamma in dorsal striatum. [PDF]
Jiang L +22 more
europepmc +1 more source
Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysis. [PDF]
Chiappa NF, Lal N, Botchwey EA.
europepmc +1 more source
Multi-omics insights into GBA1-associated Parkinson's disease: interplay of genomics, transcriptomics, proteomics, and lipidomics. [PDF]
Ni Y, Cai H, Shao Y, Le W.
europepmc +1 more source

